Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06209476 · ClinicalTrials.gov registry record

Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error

A clinical trial, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
30
Enrollment target

NCT06209476 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06209476 has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

This is a unilateral, non-interventional study. Each subject will be unilaterally measured with the WAM-5500 autorefractor by 3 testers. All measurements will be made on the right eye only.

Interventions

  • DIAGNOSTIC_TEST Experimental

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-01-16
Est. Completion 2024-02-05

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT06209476

The ClinicalTrials.gov registry entry for NCT06209476 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Experimental is the first listed.

NCT06209476 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06209476 about?

NCT06209476 is a clinical study titled "Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error". This is a unilateral, non-interventional study. Each subject will be unilaterally measured with the WAM-5500 autorefractor by 3 testers. All measurements will be made on the right eye only.

What is the current status of trial NCT06209476?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2024-01-16. Estimated completion is 2024-02-05.

What interventions are being tested in trial NCT06209476?

The interventions under investigation include: Experimental (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06209476?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.